X
FDA rejects Pharming’s Ruconest HAE label expansion
https://pharmaphorum.com/news/fda-rejects-pharmings-ruconest-hae-label-expansion/
Shire
Servier expands global footprint post Shire deal
Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.
Roche haemophilia data piles pressure on Shire
Hemlibra threatens to take market share from Advate
Takeda to cut IT, marketing and sales jobs after Shire merger
Takeda aiming for $1.4bn savings per year
